Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'PRICE or mdpv' OR with Authors including 'PRICE or mdpv' OR with Abstract including 'PRICE or mdpv' OR with Keywords including 'PRICE or mdpv'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
S Cohen What Price Morning Glory? Mind 1964
Cohen S A classification of LSD complications Psychosomatics 1966
Geiger RS, Rothman A, Sus... LSD effects on mature and immature brain cells in culture Fed. Proc. 1968
Eisner, BG The Group as Means and Matrix for Change Symposium Paper: On ... 1971
Guha D, Pradhan SN Mescaline PharmChem Newsletter 1972
Young RE, Milroy R, Hutch... The Rising Price Of Mushrooms The Lancet 1982
Renfroe CL, Messinger TA Street drug analysis: an eleven year perspective on illicit drug alter... Semin Adolesc Med 1985
Charney DS, Goodman WK, P... Serotonin function in obsessive-compulsive disorder A comparison of th... Arch Gen Psychiatry 1988
Price LH, Ricaurte GA, Kr... Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-m... Arch Gen Psychiatry 1989
Price LH, Ricaurte GA, Kr... Responses to I.V. L-tryptophan in MDMA Users NIDA Res Monogr 1989
Olney JW, Labruyere J, Pr... Pathological changes induced in cerebrocortical neurons by phencyclidi... Science 1989
Grob C, Bravo G, Walsh R Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxic... Arch Gen Psychiatry 1990
Olney JW, Labruyere J, Wa... NMDA antagonist neurotoxicity: mechanism and prevention Science 1991
Kosten TR, Price LH Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use [C... Journal of Nervous &... 1992
Krystal JH, Price LH, Ops... Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood ... Am J Drug Alcohol Ab... 1992
Schifano F, Magni G MDMA ('ecstasy') abuse: psychopathological features and craving for ch... Biol Psychiatry 1994
Edwards JG, Anderson I Systematic review and guide to selection of selective serotonin reupta... Drugs 1999
Montoya AG, Sorrentino R,... Long-Term Neuropsychiatric Consequences of 'Ecstasy' (MDMA): A Review Harv Rev Psychiatry 2002
Goldberger BA, Frost-Pine... Ecstasy Deaths in the State of Florida: A Post-Mortem Analysis Biol Psych 2002
Wilkins C, Bhatta K, Pled... Ecstasy use in New Zealand: findings from the 1998 and 2001 National D... N Z Med J 2003
Uchiyama N, Kikura-Hanaji... [Analysis of designer drugs detected in the products purchased in fisc... Yakugaku Zasshi 2008
Yohannan JC, Bozenko JS The Characterization of 3,4-Methylenedioxypyrovalerone (MDPV) Microgram Journal 2010
Brandt SD, Sumnall HR, Me... Analyses of second-generation 'legal highs' in the UK: Initial finding... Drug Test Anal 2010
Winstock A, Mitcheson L, ... Mephedrone: still available and twice the price Lancet 2010
Durham M Ivory wave: the next mephedrone? Emerg Med J 2011
Carhart-Harris RL, King L... A web-based survey on mephedrone Drug Alcohol Depend 2011
Antonowicz JL, Metzger AK... Paranoid psychosis induced by consumption of methylenedioxypyrovaleron... Gen Hosp Psychiatry 2011
Editors Emergency department visits after use of a drug sold as 'bath salts'--... MMWR Morb Mortal Wkl... 2011
Spiller HA, Ryan ML, West... Clinical experience with and analytical confirmation of 'bath salts' a... Clin Toxicol (Phila) 2011
Penders TM, Gestring R Hallucinatory delirium following use of MDPV: 'Bath Salts' Gen Hosp Psychiatry 2011
Editors Legal Drugs of Abuse Emerg Med Rep 2011
Coppola M, Mondola R 3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and tox... Toxicol Lett 2011
Reitzel LA, Dalsgaard PW,... Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and N... Drug Test Anal 2011
Kyle PB, Iverson RB, Gaja... Illicit bath salts: not for bathing J Miss State Med Ass... 2011
Rosenbaum CD, Carreiro SP... Here Today, Gone Tomorrow...and Back Again? A Review of Herbal Marijua... J Med Toxicol 2012
Van Hout MC, Bingham T 'A Costly Turn On': Patterns of use and perceived consequences of meph... Int J Drug Policy 2012
Fass JA, Fass AD, Garcia ... Synthetic Cathinones (Bath Salts): Legal Status and Patterns of Abuse ... Ann Pharmacother 2012
Olives TD, Orozco BS, Ste... Bath salts: the ivory wave of trouble West J Emerg Med 2012
Murray BL, Murphy CM, Beu... Death following recreational use of designer drug 'bath salts' contain... J Med Toxicol 2012
Prosser JM, Nelson LS The Toxicology of Bath Salts: A Review of Synthetic Cathinones J Med Toxicol 2012
Coppola M, Mondola R Synthetic cathinones: Chemistry, pharmacology and toxicology of a new ... Toxicol Lett 2012
Jerry J, Collins G, Stree... Synthetic legal intoxicating drugs: The emerging 'incense' and 'bath s... Cleve Clin J Med 2012
Thornton SL, Gerona RR, T... Psychosis from a Bath Salt Product Containing Flephedrone and MDPV wit... J Med Toxicol 2012
Macher AM, Penders TM False-positive phencyclidine immunoassay results caused by 3,4-methyle... Drug Test Anal 2012
Ross EA, Reisfield GM, Wa... Psychoactive 'Bath Salts' Intoxication with Methylenedioxypyrovalerone Am J Med 2012
Watterson LR, Kufahl PR, ... Potent rewarding and reinforcing effects of the synthetic cathinone 3,... Addict Biol 2012
Cameron KN, Kolanos R, So... Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV)... Br J Pharmacol 2012
Simmler LD, Buser TA, Don... Pharmacological characterization of designer cathinones in vitro Br J Pharmacol 2013
Cameron K, Kolanos R, Ver... Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents o... Psychopharmacology (... 2013
Wyman JF, Lavins ES, Enge... Postmortem Tissue Distribution of MDPV Following Lethal Intoxication b... J Anal Toxicol 2013
Baumann MH, Partilla JS, ... Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV)... Neuropsychopharmacol... 2013
Fantegrossi WE, Gannon BM... In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypy... Neuropsychopharmacol... 2013
Johnson LA, Johnson RL, P... Current 'Legal Highs' J Emerg Med 2013
Marinetti LJ, Antonides H... Analysis of synthetic cathinones commonly found in bath salts in human... J Anal Toxicol 2013
Merluzzi AP, Hurwitz Z, B... Differential Expression of MDPV-Induced Taste Aversions and Thermoregu... FASEB Journal 2013
Simojoki K, Alho H A Five-Year Follow-up of Buprenorphine Abuse Potential J Alcoholism Drug De... 2013
Aarde SM, Huang PK, Creeh... The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a... Neuropharmacology 2013
Seely KA, Patton AL, Mora... Forensic investigation of K2, Spice, and bath salt commercial preparat... Forensic Sci Int 2013
Lawn W, Barratt M, Willia... The NBOMe hallucinogenic drug series: Patterns of use, characteristics... J Psychopharmacol 2014
Nizar H, Dargan PI, Wood ... Using internet snapshot surveys to enhance our understanding of the av... J Med Toxicol 2015
Armenian P, Thornton S, G... Ease of Identifying and Purchasing Popular Research Chemicals via the ... NACCT 2015
Adamowicz P, Gieron J, Gi... The prevalence of new psychoactive substances in biological material -... Drug Test Anal 2015
Wojcieszak J, Andrzejczak... Cytotoxic Activity of Pyrovalerone Derivatives, an Emerging Group of P... Neurotox Res 2016
Odoardi S, Romolo FS, Str... A snapshot on NPS in Italy: Distribution of drugs in seized materials ... Forensic Sci Int 2016
Bade R, Bijlsma L, Sancho... Liquid chromatography-tandem mass spectrometry determination of synthe... Chemosphere 2016
van der Gouwe D, Brunt TM... Purity, adulteration and price of drugs bought online versus offline i... Addiction 2017
Aldridge J, Stevens A, Ba... Will growth in cryptomarket drug buying increase the harms of illicit ... Addiction 2017
Karila L, Lafaye G, Scoca... MDPV and α-PVP use in humans: The twisted sisters Neuropharmacology 2017
Moosmann B, Auwärter V Designer Benzodiazepines: Another Class of New Psychoactive Substances Handb Exp Pharmacol 2018
Zaami S, Giorgetti R, Pic... Synthetic cathinones related fatalities: an update Eur Rev Med Pharmaco... 2018
Abouchedid R, Gilks T, Da... Assessment of the Availability, Cost, and Motivations for Use over Tim... J Med Toxicol 2018